Author(s): Fuster MM, Esko JD
Abstract Share this page
Abstract A growing body of evidence supports crucial roles for glycans at various pathophysiological steps of tumour progression. Glycans regulate tumour proliferation, invasion, haematogenous metastasis and angiogenesis, and increased understanding of these roles sets the stage for developing pharmaceutical agents that target these molecules. Such novel agents might be used alone or in combination with operative and/or chemoradiation strategies for treating cancer.
This article was published in Nat Rev Cancer
and referenced in Journal of Glycobiology